| abstract |
In certain embodiments, the present invention relates to a pharmaceutical composition for topical administration to a mammal, comprising a therapeutically effective amount of an active ingredient in a unit dosage form, and a pharmaceutically acceptable carrier medium; contact with the mammalian skin of the patient, soften to a consistency that provides the basic application of a given unit dose of active ingredient in less than 10 minutes at the desired site of the mammalian skin of the patient. SHE |